Optimization of diagnosis of pneumonia severity in COVID-19

Well-known diagnostic approaches to assessing the severity of pneumonia in clinical practice in COVID-19 did not significantly affect the reduction in the number of patients with severe disease and mortality, and along with the general clinical picture, diagnostic and laboratory visualization of it plays an important role. The aim of the study was to optimize the diagnosis of the severity of pneumonia in COVID-19. A clear dependence of the concentration of ferritin, procalcitonin and C-reactive protein in patients was revealed and established, depending on the severity of pneumonia in COVID-19. Based on the data obtained, a score assessment of the severity of pneumonia has been developed, which allows early initiation of intensive therapy for severe pneumonia, as well as rationally distribute the flows of hospitalized patients in the hospital according to the severity of pneumonia, thereby increasing the number of patients with a favorable outcome of pneumonia in COVID-19.